Etoricoxib (brand name Arcoxia worldwide; Coxyveen by Solmarc and Nucoxia in India also Algix and Tauxib in Italy Vargus by Sandoz in Bangladesh Starcox By GETS Pharma in Pakistan Exxiv by Bial in Portugal) is a COX-2 selective inhibitor (approx. 106.0 times more selective for COX-2 inhibition over COX-1) from Merck & Co.
This page contains content from the copyrighted Wikipedia article "Etoricoxib"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
